Altimmune, Inc. (ALT)

CIK 1326190 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Altimmune, Inc..

Recent SEC filings

FiledFormAccession number
Nov 4, 202630001363683-26-000007
Nov 4, 202640001363683-26-000009
Nov 4, 202640001795798-26-000009
Nov 4, 202630001795798-26-000007
Oct 29, 20268-K0001326190-26-000060
Oct 27, 20268-K0001104659-26-118991
Oct 5, 202640001802615-26-000002
Oct 5, 202640001251779-26-000011
Oct 2, 202630002156820-26-000003
Oct 2, 202640002156820-26-000004
Sep 29, 20268-K0001326190-26-000056
Sep 17, 202640001595064-26-000002
Aug 13, 202640001698665-26-000007
Aug 12, 20268-K0001326190-26-000049
Aug 12, 202610-Q0001326190-26-000052
Aug 3, 202640001705905-26-000010
Aug 3, 202640001251779-26-000009
Jul 28, 20268-K0001326190-26-000044
Jun 16, 20268-K0001104659-26-074575
May 15, 2026SCHEDULE 13G/A0001214659-26-006495
May 13, 20268-K0001326190-26-000037
May 13, 2026S-80001326190-26-000041
May 13, 202610-Q0001326190-26-000040
May 12, 2026SCHEDULE 13G0000093751-26-000201
May 1, 2026SCHEDULE 13G0000905148-26-002008